Cost Analysis of Drug-related Problems in Saudi Arabia: Patients’ and Healthcare Providers’ Perspective

Purpose: To explore the cost analysis of drug-related problems in Saudi Arabia from patient and healthcare provider’s perceptive. Methods: It is a 4-months cross-sectional survey of drug-related problem information in Saudi Arabia. The survey consisted of two-part demographic information, and second part consisted of thirteen questions focusing on general knowledge of drug-related problems, their occurrence, and costs. The questions divided into three domains. It included domain 1: Primary or essential information about knowledge and perception of drug-related problems, domain 2: The cost analysis of drug-related problems, domain 3: Clinical outcome of drug-related problems. The questions about the cost of drug-related problems, health insurance coverage and the economic outcome of those issues including pharmacy visit, ambulatory care clinic visit, an emergency visit, hospital admission, critical care admission, drug-induced death. The American Society of Health-System Pharmacist definitions of drug-related problems used. The survey distributed through social media by using what’s App to almost two thousand public and healthcare professionals overall Kingdom of Saudi Arabia. It analyzed domain two the cost analysis of drug-related problems through survey monkey system. Results: The total responders were one hundred and one. Of those 155 (77.9%) were patients while 44 (22.1%) were healthcare professionals. The gender distribution was female 180 (89.6%), and the male was 21 (10.4%). It is statistically non-significant (p Conclusion: The drug-related problems were a very high-cost burden on health care system in Saudi Arabia. Targeting to improve role of pharmacist and prevent drug-related misadventures is highly recommended through Saudi Health Care Vision 2030. Key words: Cost analysis, Drug-related problems, Patients, Healthcare providers, Perspective, Saudi Arabia.

• Publication year

  2018

• Venue

  Journal of Pharmacy Practice and Community Medicine

• Publication date

  2018-06-10

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.5530/jppcm.2018.2.24
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• ASHP Statement on Pharmaceutical Care

  2019cited by this paper
• Aspirin use and pancreatic cancer risk

  2019cited by this paper
• Economic impact of medication error: a systematic review

  2017cited by this paper
• Cost-Efficiency Of Medication Safety Program At Pediatrics, Obstetrics, And Gynecology Hospital, East Province, Saudi Arabia

  2016cited by this paper
• Cost Avoidance Of Pharmacist Running Pediatrics Total Parenteral Nutrition Services At Ministry Of Health In Saudi Arabia

  2016cited by this paper
• Clinical And Economic Outcomes Of Pharmacist Intervention During Therapeutic Drug Monitoring Program In Saudi Arabia

  2016cited by this paper
• Admissions for drug-related problems at the Emergency Department of a University Hospital in the Kingdom of Saudi Arabia

  2015cited by this paper
• DRUG RELATED PROBLEMS: AN OVER VIEW OF VARIOUS CLASSIFICATION SYSTEMS

  2014cited by this paper
• Characteristics, procedural differences, and costs of inpatients with drug poisoning in acute care hospitals in Japan.

  2012cited by this paper
• Drug-drug interactions associated with length of stay and cost of hospitalization.

  2009cited by this paper
• Drug-related morbidity and mortality: updating the cost-of-illness model.

  2001cited by this paper
• The health care cost of drug-related morbidity and mortality in nursing facilities.

  1997cited by this paper
• Drug-related morbidity and mortality and the economic impact of pharmaceutical care.

  1997cited by this paper
• ASHP guidelines on a standardized method for pharmaceutical care. American Society of Health-System Pharmacists.

  1996cited by this paper
• Drug-related morbidity and mortality. A cost-of-illness model.

  1995cited by this paper
• Drug-Related Problems: Their Structure and Function

  1990cited by this paper

• Potential and Risks Behind the National Transformation Program in Saudi Arabia

  2024cites this paper
• Clinical pharmacist interventions in an intensive care unit reduces ICU mortality at a tertiary hospital in Dubai, United Arab Emirates

  2024cites this paper
• Perception of Pharmacists About the High-Risk/Alert Medications in Saudi Arabia Abstract

  2023cites this paper
• Antibiotic Prescribing Pattern; Errors Perspective in Primary Health Care Centers in Riyadh City, Saudi Arabia

  2023cites this paper
• Estimating the potential economic impact of the Wasfaty program on costs of antidiabetic treatment: An initiative for the digital transformation of health

  2023cites this paper
• Physician’s Knowledge of Adverse Drug Reaction in Saudi Arabia

  2021cites this paper
• Dentist’s Practice of Medication Safety in Saudi Arabia

  2021cites this paper
• National Pharmacist Intervention Documentation System at the Ministry of Health in Saudi Arabia

  2019cites this paper
• National Medication Errors Reporting System at Ministry of Health in Saudi Arabia

  2019cites this paper
• Cost-Efficiency of Medication Safety Program at Public Hospital, Riyadh, Saudi Arabia

  2019cites this paper
• Basic Knowledge of Non-steroidal Anti-inflammatory Drugs among Saudi Community

  2019cites this paper
• Children drug poisoning in Jeddah: Prevalence, pattern and mother’s practice

  2019cites this paper